Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
about
The endocannabinoid system in normal and pathological brain ageingInflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical diseaseLow-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytesMouse models to study the effect of cardiovascular risk factors on brain structure and cognitionApolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.LDL receptor knock-out mice show impaired spatial cognition with hippocampal vulnerability to apoptosis and deficits in synapses.Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureLow-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis.Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's diseaseApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditionsFunctional Roles of the Interaction of APP and Lipoprotein Receptors.Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease.Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model.Low-density lipoprotein receptor: a promising therapeutic target to promote cerebral beta-amyloid clearance?ApoE facilitates the microglial response to amyloid plaque pathology.
P2860
Q22242668-4ECDDA03-0BE4-4A63-8EBE-5A5D96655969Q27023953-D9EB5273-1FCA-439C-B5D1-148C30A5036FQ30274560-13E60863-E75D-4F78-A82D-0B2F638C348BQ30427103-1D3C66AE-7C62-4E7E-A634-77292B061DB7Q30572801-027A1835-2772-4225-8780-6C1B85885EB5Q33830137-010A3603-CBD8-45C2-AEFB-801FC40CD72CQ34643378-EC26785C-2FEC-4FED-9796-CD7697139147Q35127516-33BC3792-0E9B-403C-8352-BFE78A3DD4F6Q36279902-CC4F6B46-36B5-4A70-BD96-AE9598964E33Q36424857-5FD3E78E-1496-4F64-8106-A779866128FDQ36835522-F1DB620A-03B5-4E49-B75E-FD71C81B910FQ39180867-92D0B6D0-E7F7-410F-9737-2A56AC8A6A4CQ39257249-F2AC2511-9222-4D50-8ADC-29DD61DD5FE6Q42321517-C0800B65-5498-4101-AEBD-6ACF054E97B8Q46527301-B704D512-4CD2-45FD-9A4E-53BC6287173DQ48621590-12366342-5458-4644-A1FE-0FF488871F7EQ51747334-69930C10-62AC-4BDA-B106-5E23434C51C0
P2860
Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lack of LDL receptor enhances ...... zheimer's disease mouse model.
@ast
Lack of LDL receptor enhances ...... zheimer's disease mouse model.
@en
type
label
Lack of LDL receptor enhances ...... zheimer's disease mouse model.
@ast
Lack of LDL receptor enhances ...... zheimer's disease mouse model.
@en
prefLabel
Lack of LDL receptor enhances ...... zheimer's disease mouse model.
@ast
Lack of LDL receptor enhances ...... zheimer's disease mouse model.
@en
P2860
P1433
P1476
Lack of LDL receptor enhances ...... zheimer's disease mouse model.
@en
P2093
Loukia Katsouri
Spiros Georgopoulos
P2860
P304
P356
10.1371/JOURNAL.PONE.0021880
P407
P577
2011-07-06T00:00:00Z